Literature DB >> 16569566

The extracardiac lateral tunnel Fontan, constructed with bovine pericardium: comparison with the extracardiac conduit Fontan.

Matthew S Lemler1, Claudio Ramaciotti, Daniel Stromberg, William A Scott, Steven R Leonard.   

Abstract

BACKGROUND: The Fontan procedure performed with an extracardiac conduit (ECC) has gained wide acceptance as an alternative to the intracardiac lateral tunnel because it avoids placement of extensive atrial suture lines and use of prosthetic material in the systemic circulation. The extracardiac lateral tunnel (ELT) is a modification of the Fontan procedure which uses pericardium and the external surface of the atrium to create a conduit from the inferior vena cava to the pulmonary artery. This surgery theoretically avoids disruption of intra-atrial conduction by eschewing endocardial suturing while maintaining conduit growth potential and the ability to easily create a fenestration to the systemic circulation.
METHODS: We retrospectively analyzed the short-term outcome of 96 consecutive patients who underwent an extracardiac Fontan procedure. An ELT using bovine pericardium was performed in 59 patients, whereas 37 patients received a traditional ECC.
RESULTS: The 2 groups were similar with respect to age (P = .96), body surface area (P = .54), number of preoperative Fontan risk factors (P = .43), and ventricular morphology (P = .72). There were no significant differences in the following outcome variables between the ELT and the traditional ECC: length of hospitalization (P = .73), duration of chest tube drainage (P = .48), abnormal rhythm at time of discharge (P = .27), and mortality (P = .63).
CONCLUSIONS: The ELT Fontan can be performed with a low risk of mortality and complications. The results are equivalent to the traditional ECC procedure. The theoretical advantages of the procedure suggest that it should be considered a useful modification of Fontan surgery.

Entities:  

Mesh:

Year:  2006        PMID: 16569566     DOI: 10.1016/j.ahj.2005.06.015

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  5 in total

Review 1.  Evaluating the Longevity of the Fontan Pathway.

Authors:  John M Kelly; Gabriel J M Mirhaidari; Yu-Chun Chang; Toshiharu Shinoka; Christopher K Breuer; Andrew R Yates; Kan N Hor
Journal:  Pediatr Cardiol       Date:  2020-11-08       Impact factor: 1.655

Review 2.  Antiplatelet versus anticoagulation therapy after extracardiac conduit Fontan: a systematic review and meta-analysis.

Authors:  Chiara Marrone; Gennaro Galasso; Raffaele Piccolo; Francesco de Leva; Rodolfo Paladini; Federico Piscione; Giuseppe Santoro
Journal:  Pediatr Cardiol       Date:  2010-10-22       Impact factor: 1.655

Review 3.  The Long-Term Management of Children and Adults with a Fontan Circulation: A Systematic Review and Survey of Current Practice in Australia and New Zealand.

Authors:  Ganesh K Gnanappa; David S Celermajer; Gary F Sholler; Tom Gentles; David Winlaw; Yves d'Udekem; Julian Ayer
Journal:  Pediatr Cardiol       Date:  2016-10-27       Impact factor: 1.655

4.  Long-term results of cell-free biodegradable scaffolds for in situ tissue-engineering vasculature: in a canine inferior vena cava model.

Authors:  Goki Matsumura; Naotaka Nitta; Shojiro Matsuda; Yuki Sakamoto; Noriko Isayama; Kenji Yamazaki; Yoshito Ikada
Journal:  PLoS One       Date:  2012-04-19       Impact factor: 3.240

Review 5.  Decision-Making for Surgery in the Management of Patients with Univentricular Heart.

Authors:  Ryan Robert Davies; Christian Pizarro
Journal:  Front Pediatr       Date:  2015-07-27       Impact factor: 3.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.